目次 | Nature Medicine | Nature Portfolio
Brief Communications | Nature Medicine
Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2 | Nature Medicine
Respiratory virus shedding in exhaled breath and efficacy of face masks | Nature Medicine
Seasonal coronavirus protective immunity is short-lasting | Nature Medicine
Brief Communications in 2020 | Nature Medicine
Brief Communications | Nature Medicine
Development of a CRISPR/Cas9-based therapy for Hutchinson–Gilford progeria syndrome | Nature Medicine
Brief Communications in 2017 | Nature Medicine
Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy | Nature Medicine
Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination | Nature Medicine
Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes | Nature Medicine
Brief Communications in 2020 | Nature Medicine
Brief Communications in 2020 | Nature Medicine
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera | Nature Medicine
Brief Communications | Nature Medicine
Brief Communications | Nature Medicine
Volume 27 Issue 5, May 2021
A serological assay to detect SARS-CoV-2 seroconversion in humans | Nature Medicine
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes | Nature Medicine
The future of personalized brain stimulation | Nature Medicine
p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells | Nature Medicine
Nature Medicine
Brief Communications in 2019 | Nature Medicine
